[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"intravenous-chemotherapy-versus-intraperitoneal-chemotherapy-in-recurrent-ovarian-cancer\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:intravenous-chemotherapy-versus-intraperitoneal-chemotherapy-in-recurrent-ovarian-cancer":14},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":25,"lastUpdatePostDateStruct":26,"startDateStruct":29,"completionDateStruct":31,"leadSponsor":33,"locationsCount":5},"100557224","intraperitoneal-chemotherapy-in-recurrent-ovarian-cancer-100557224",false,"NCT06535334","Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer","Intravenous Chemotherapy Versus Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer","Inclusion Criteria:\n\n* women who had recurrent ovarian cancer and was treated with either intravenous or intraperitoneal platinum based chemotherapy\n\nExclusion Criteria:\n\n* women who did not complete the designated treatment course (exception to those who had to quit due to progressive disease or death of any cause)","FEMALE","20 Years",{"count":19,"type":20},80,"ESTIMATED","OBSERVATIONAL","This study aims to compare intravenous chemotherapy versus intraperitoneal chemotherapy in patients with recurrent ovarian cancer.",[14],"NOT_YET_RECRUITING","2024-07-31",{"date":27,"type":28},"2024-08-02","ACTUAL",{"date":30,"type":20},"2024-08-15",{"date":32,"type":20},"2026-05",{"name":34,"class":35},"Far Eastern Memorial Hospital","OTHER"]